Susquehanna International Group’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-30,917
| Closed | -$866K | – | 14562 |
|
|
2022
Q1 | $866K | Sell |
30,917
-17,774
| -37% | -$487K | ﹤0.01% | 7505 |
|
|
2021
Q4 | $1.33M | Buy |
48,691
+14,477
| +42% | +$392K | ﹤0.01% | 6509 |
|
|
2021
Q3 | $931K | Buy |
34,214
+8,674
| +34% | +$214K | ﹤0.01% | 7751 |
|
|
2021
Q2 | $436K | Buy |
+25,540
| New | +$478K | ﹤0.01% | 9920 |
|
|
2021
Q1 | – | Sell |
-10,566
| Closed | -$244K | – | 13095 |
|
|
2020
Q4 | $242K | Buy |
+10,566
| New | +$201K | ﹤0.01% | 9719 |
|
|
2020
Q2 | – | Sell |
-23,227
| Closed | -$275K | – | 11272 |
|
|
2020
Q1 | $275K | Sell |
23,227
-59,036
| -72% | -$1.31M | ﹤0.01% | 8148 |
|
|
2019
Q4 | $2.05M | Buy |
82,263
+55,727
| +210% | +$1.13M | ﹤0.01% | 4286 |
|
|
2019
Q3 | $451K | Sell |
26,536
-23,878
| -47% | -$435K | ﹤0.01% | 7526 |
|
|
2019
Q2 | $1.15M | Buy |
+50,414
| New | +$1.36M | ﹤0.01% | 5343 |
|
|
2019
Q1 | – | Sell |
-16,548
| Closed | -$512K | – | 10192 |
|
|
2018
Q4 | $466K | Buy |
+16,548
| New | +$485K | ﹤0.01% | 6169 |
|
|
2018
Q2 | – | Sell |
-12,910
| Closed | -$507K | – | 10709 |
|
|
2018
Q1 | $507K | Sell |
12,910
-57,397
| -82% | -$2.1M | ﹤0.01% | 6613 |
|
|
2017
Q4 | $2.28M | Buy |
+70,307
| New | +$2.11M | ﹤0.01% | 3676 |
|
|
2017
Q3 | – | Sell |
-81,644
| Closed | -$2.42M | – | 9913 |
|
|
2017
Q2 | $2.28M | Buy |
81,644
+43,244
| +113% | +$979K | ﹤0.01% | 3681 |
|
|
2017
Q1 | $659K | Sell |
38,400
-1,370
| -3% | -$19.2K | ﹤0.01% | 5975 |
|
|
2016
Q4 | $481K | Buy |
+39,770
| New | +$515K | ﹤0.01% | 7081 |
|
|
2016
Q1 | – | Sell |
-10,624
| Closed | -$239K | – | 9894 |
|
|
2015
Q4 | $239K | Buy |
+10,624
| New | +$210K | ﹤0.01% | 8124 |
|
Susquehanna International Group's XENT Position: Q2 2022 in Review
Susquehanna International Group sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 30,917 shares — an estimated $866K sold.
Susquehanna International Group first reported a position in XENT in Q4 2015 and held it in 16 quarters. The position peaked at $2.28M in Q2 2017. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Susquehanna International Group reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Susquehanna International Group sold 30,917 Intersect ENT, Inc shares in Q2 2022, an estimated $866K.
- Susquehanna International Group first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 16 quarters.
- Susquehanna International Group's Intersect ENT, Inc position peaked at $2.28M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.